SCHEMBL7797478

SCHEMBL7797478

COc1ccccc1C(=O)C[C@@H](N)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.56
KDM4E B2RXH2 1/20 0.54
HIF1A Q16665 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
CTSD P07339 1/20 0.53
GRIK1 P39086 1/20 0.50
GRIK2 Q13002 1/20 0.50
GRIK3 Q13003 1/20 0.50
HTT P42858 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
ALDH1A1 P00352 2/20 0.48
KMT2A Q03164 2/20 0.48
POLB P06746 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
IDO1 P14902 1/20 0.47
TDO2 P48775 1/20 0.47
CTNNB1 P35222 1/20 0.47
WNT3A P56704 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC1 Q13547 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7797468 1.00 NPC1 (0.56) NPC1KDM4EHIF1ATDP1CTSD
SCHEMBL7797480 1.00 NPC1 (0.56) NPC1KDM4EHIF1ATDP1CTSD
Hydrochloric Acid SCHEMBL27448520 0.98 NPC1 (0.55) NPC1KDM4EHIF1ATDP1CTSD
Hydrochloric Acid SCHEMBL27416697 0.98 NPC1 (0.55) NPC1KDM4EHIF1ATDP1CTSD
Hydrochloric Acid SCHEMBL27416698 0.98 NPC1 (0.55) NPC1KDM4EHIF1ATDP1CTSD
SCHEMBL9065648 0.87 KDM4E (0.69) NPC1KDM4EHIF1ATDP1CTSD
SCHEMBL25712016 0.84 CTSD (0.56) NPC1CTSDHTTL3MBTL1ALDH1A1
SCHEMBL7799546 0.82 GRIK1 (0.43) NPC1KDM4EHIF1ATDP1GRIK1
SCHEMBL7799550 0.82 GRIK1 (0.43) NPC1KDM4EHIF1ATDP1GRIK1
SCHEMBL7801989 0.82 GRIK1 (0.43) NPC1KDM4EHIF1ATDP1GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES VARASI MARIO (IT) 2001-07-19 US disclosed
EP-0662948-B1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN SPA (IT) 1998-10-07 EP disclosed
EP-0662948-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.p.A. (IT) 1995-07-19 EP disclosed
WO-1995003271-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA S.P.A. (IT) 1995-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES KYNU, KMO, ABAT NPC1 3435/4885KDM4E 122/4885HIF1A 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.